Stock Analysis on Net
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Adjusted Financial Ratios

Microsoft Excel

Adjusted Financial Ratios (Summary)

Allergan PLC, adjusted financial ratios

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Activity Ratio
Total Asset Turnover
Reported 0.17 0.16 0.13 0.11 0.11
Adjusted 0.17 0.16 0.13 0.11 0.11
Liquidity Ratio
Current Ratio
Reported 1.01 1.13 1.16 2.27 1.03
Adjusted 1.02 1.16 1.18 2.30 1.06
Solvency Ratios
Debt to Equity
Reported 0.39 0.37 0.41 0.43 0.56
Adjusted 0.37 0.35 0.38 0.37 0.51
Debt to Capital
Reported 0.28 0.27 0.29 0.30 0.36
Adjusted 0.27 0.26 0.28 0.27 0.34
Financial Leverage
Reported 1.63 1.56 1.60 1.69 1.77
Adjusted 1.52 1.45 1.48 1.45 1.60
Profitability Ratios
Net Profit Margin
Reported -32.76% -32.28% -25.88% 102.76% 25.98%
Adjusted -38.09% -44.06% -52.80% -24.49% -30.34%
Return on Equity (ROE)
Reported -9.06% -7.83% -5.59% 19.65% 5.11%
Adjusted -9.85% -9.96% -10.51% -4.00% -5.39%
Return on Assets (ROA)
Reported -5.57% -5.01% -3.49% 11.61% 2.88%
Adjusted -6.50% -6.87% -7.11% -2.76% -3.36%

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

Financial ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Allergan PLC adjusted total asset turnover ratio improved from 2017 to 2018 and from 2018 to 2019.
Adjusted current ratio A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities. Allergan PLC adjusted current ratio deteriorated from 2017 to 2018 and from 2018 to 2019.
Adjusted debt-to-equity ratio A solvency ratio calculated as adjusted total debt divided by adjusted total equity. Allergan PLC adjusted debt-to-equity ratio improved from 2017 to 2018 but then slightly deteriorated from 2018 to 2019 not reaching 2017 level.
Adjusted debt-to-capital ratio A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Allergan PLC adjusted debt-to-capital ratio improved from 2017 to 2018 but then slightly deteriorated from 2018 to 2019 not reaching 2017 level.
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.		 Allergan PLC adjusted financial leverage ratio decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by total revenue. Allergan PLC adjusted net profit margin ratio improved from 2017 to 2018 and from 2018 to 2019.
Adjusted ROE A profitability ratio calculated as adjusted net income divided by adjusted total equity. Allergan PLC adjusted ROE improved from 2017 to 2018 and from 2018 to 2019.
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Allergan PLC adjusted ROA improved from 2017 to 2018 and from 2018 to 2019.

Allergan PLC, Financial Ratios: Reported vs. Adjusted

Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Net revenues 16,088,900 15,787,400 15,940,700 14,570,600 15,071,000
Total assets 94,699,100 101,787,600 118,341,900 128,986,300 135,840,700
Activity Ratio
Total asset turnover1 0.17 0.16 0.13 0.11 0.11
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net revenues2 16,079,400 15,785,600 15,962,900 14,568,100 15,062,900
Adjusted total assets3 94,233,000 101,182,473 118,497,881 129,118,922 136,034,381
Activity Ratio
Adjusted total asset turnover4 0.17 0.16 0.13 0.11 0.11

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
Total asset turnover = Net revenues ÷ Total assets
= 16,088,900 ÷ 94,699,100 = 0.17

2 Adjusted net revenues. See details »

3 Adjusted total assets. See details »

4 2019 Calculation
Adjusted total asset turnover = Adjusted net revenues ÷ Adjusted total assets
= 16,079,400 ÷ 94,233,000 = 0.17

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Allergan PLC adjusted total asset turnover ratio improved from 2017 to 2018 and from 2018 to 2019.

Adjusted Current Ratio

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Current assets 11,126,700 6,475,400 11,376,700 17,857,900 8,615,400
Current liabilities 11,070,700 5,727,900 9,848,100 7,874,700 8,328,300
Liquidity Ratio
Current ratio1 1.01 1.13 1.16 2.27 1.03
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted current assets2 11,237,500 6,577,100 11,469,700 17,933,600 8,696,000
Adjusted current liabilities3 11,058,000 5,656,300 9,715,300 7,788,500 8,210,300
Liquidity Ratio
Adjusted current ratio4 1.02 1.16 1.18 2.30 1.06

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
Current ratio = Current assets ÷ Current liabilities
= 11,126,700 ÷ 11,070,700 = 1.01

2 Adjusted current assets. See details »

3 Adjusted current liabilities. See details »

4 2019 Calculation
Adjusted current ratio = Adjusted current assets ÷ Adjusted current liabilities
= 11,237,500 ÷ 11,058,000 = 1.02

Liquidity ratio Description The company
Adjusted current ratio A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities. Allergan PLC adjusted current ratio deteriorated from 2017 to 2018 and from 2018 to 2019.

Adjusted Debt to Equity

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Total debt 22,649,000 23,797,700 30,075,300 32,768,700 42,726,200
Shareholders’ equity 58,173,600 65,114,100 73,821,100 76,192,700 76,591,400
Solvency Ratio
Debt to equity1 0.39 0.37 0.41 0.43 0.56
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 23,219,500 24,154,573 30,457,381 33,058,922 42,888,781
Adjusted total equity3 62,173,300 69,820,600 80,215,900 89,164,000 84,805,600
Solvency Ratio
Adjusted debt to equity4 0.37 0.35 0.38 0.37 0.51

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity
= 22,649,000 ÷ 58,173,600 = 0.39

2 Adjusted total debt. See details »

3 Adjusted total equity. See details »

4 2019 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity
= 23,219,500 ÷ 62,173,300 = 0.37

Solvency ratio Description The company
Adjusted debt-to-equity ratio A solvency ratio calculated as adjusted total debt divided by adjusted total equity. Allergan PLC adjusted debt-to-equity ratio improved from 2017 to 2018 but then slightly deteriorated from 2018 to 2019 not reaching 2017 level.

Adjusted Debt to Capital

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Total debt 22,649,000 23,797,700 30,075,300 32,768,700 42,726,200
Total capital 80,822,600 88,911,800 103,896,400 108,961,400 119,317,600
Solvency Ratio
Debt to capital1 0.28 0.27 0.29 0.30 0.36
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total debt2 23,219,500 24,154,573 30,457,381 33,058,922 42,888,781
Adjusted total capital3 85,392,800 93,975,173 110,673,281 122,222,922 127,694,381
Solvency Ratio
Adjusted debt to capital4 0.27 0.26 0.28 0.27 0.34

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
Debt to capital = Total debt ÷ Total capital
= 22,649,000 ÷ 80,822,600 = 0.28

2 Adjusted total debt. See details »

3 Adjusted total capital. See details »

4 2019 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= 23,219,500 ÷ 85,392,800 = 0.27

Solvency ratio Description The company
Adjusted debt-to-capital ratio A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Allergan PLC adjusted debt-to-capital ratio improved from 2017 to 2018 but then slightly deteriorated from 2018 to 2019 not reaching 2017 level.

Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Total assets 94,699,100 101,787,600 118,341,900 128,986,300 135,840,700
Shareholders’ equity 58,173,600 65,114,100 73,821,100 76,192,700 76,591,400
Solvency Ratio
Financial leverage1 1.63 1.56 1.60 1.69 1.77
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted total assets2 94,233,000 101,182,473 118,497,881 129,118,922 136,034,381
Adjusted total equity3 62,173,300 69,820,600 80,215,900 89,164,000 84,805,600
Solvency Ratio
Adjusted financial leverage4 1.52 1.45 1.48 1.45 1.60

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity
= 94,699,100 ÷ 58,173,600 = 1.63

2 Adjusted total assets. See details »

3 Adjusted total equity. See details »

4 2019 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity
= 94,233,000 ÷ 62,173,300 = 1.52

Solvency ratio Description The company
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.		 Allergan PLC adjusted financial leverage ratio decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.

Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Net income (loss) attributable to shareholders (5,271,000) (5,096,400) (4,125,500) 14,973,400 3,915,200
Net revenues 16,088,900 15,787,400 15,940,700 14,570,600 15,071,000
Profitability Ratio
Net profit margin1 -32.76% -32.28% -25.88% 102.76% 25.98%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income (loss)2 (6,125,400) (6,954,700) (8,427,800) (3,567,900) (4,570,700)
Adjusted net revenues3 16,079,400 15,785,600 15,962,900 14,568,100 15,062,900
Profitability Ratio
Adjusted net profit margin4 -38.09% -44.06% -52.80% -24.49% -30.34%

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
Net profit margin = 100 × Net income (loss) attributable to shareholders ÷ Net revenues
= 100 × -5,271,000 ÷ 16,088,900 = -32.76%

2 Adjusted net income (loss). See details »

3 Adjusted net revenues. See details »

4 2019 Calculation
Adjusted net profit margin = 100 × Adjusted net income (loss) ÷ Adjusted net revenues
= 100 × -6,125,400 ÷ 16,079,400 = -38.09%

Profitability ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as adjusted net income divided by total revenue. Allergan PLC adjusted net profit margin ratio improved from 2017 to 2018 and from 2018 to 2019.

Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Net income (loss) attributable to shareholders (5,271,000) (5,096,400) (4,125,500) 14,973,400 3,915,200
Shareholders’ equity 58,173,600 65,114,100 73,821,100 76,192,700 76,591,400
Profitability Ratio
ROE1 -9.06% -7.83% -5.59% 19.65% 5.11%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income (loss)2 (6,125,400) (6,954,700) (8,427,800) (3,567,900) (4,570,700)
Adjusted total equity3 62,173,300 69,820,600 80,215,900 89,164,000 84,805,600
Profitability Ratio
Adjusted ROE4 -9.85% -9.96% -10.51% -4.00% -5.39%

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
ROE = 100 × Net income (loss) attributable to shareholders ÷ Shareholders’ equity
= 100 × -5,271,000 ÷ 58,173,600 = -9.06%

2 Adjusted net income (loss). See details »

3 Adjusted total equity. See details »

4 2019 Calculation
Adjusted ROE = 100 × Adjusted net income (loss) ÷ Adjusted total equity
= 100 × -6,125,400 ÷ 62,173,300 = -9.85%

Profitability ratio Description The company
Adjusted ROE A profitability ratio calculated as adjusted net income divided by adjusted total equity. Allergan PLC adjusted ROE improved from 2017 to 2018 and from 2018 to 2019.

Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Reported
Selected Financial Data (US$ in thousands)
Net income (loss) attributable to shareholders (5,271,000) (5,096,400) (4,125,500) 14,973,400 3,915,200
Total assets 94,699,100 101,787,600 118,341,900 128,986,300 135,840,700
Profitability Ratio
ROA1 -5.57% -5.01% -3.49% 11.61% 2.88%
Adjusted
Selected Financial Data (US$ in thousands)
Adjusted net income (loss)2 (6,125,400) (6,954,700) (8,427,800) (3,567,900) (4,570,700)
Adjusted total assets3 94,233,000 101,182,473 118,497,881 129,118,922 136,034,381
Profitability Ratio
Adjusted ROA4 -6.50% -6.87% -7.11% -2.76% -3.36%

Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31).

1 2019 Calculation
ROA = 100 × Net income (loss) attributable to shareholders ÷ Total assets
= 100 × -5,271,000 ÷ 94,699,100 = -5.57%

2 Adjusted net income (loss). See details »

3 Adjusted total assets. See details »

4 2019 Calculation
Adjusted ROA = 100 × Adjusted net income (loss) ÷ Adjusted total assets
= 100 × -6,125,400 ÷ 94,233,000 = -6.50%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as adjusted net income divided by adjusted total assets. Allergan PLC adjusted ROA improved from 2017 to 2018 and from 2018 to 2019.